Concepedia

Serena Xu

SX

15

Publications

2.9K

Citations

15

H-Index

1997

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Columbia University Irving Medical Center

Cornell University

Veterans Health Administration

United States Military Academy

Serena Xu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and hiv.

Top concepts

Publications per year

1997–2020

15

Publications

15

An orally available non-nucleotide STING agonist with antitumor activity

Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 609 citations

, , +19

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

Alexandra Trkola, Shawn E. Kuhmann, Julie Strizki et al. · Proceedings of the National Academy of Sciences · 2002 · 303 citations · Full text

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection<i>in vitro</i>and<i>in vivo</i>

Julie Strizki, Serena Xu, Nicole Wagner et al. · Proceedings of the National Academy of Sciences · 2001 · 300 citations · Full text

Preclinical Characterization of<sup>18</sup>F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles

Eric D. Hostetler, Abbas Walji, Zhizhen Zeng et al. · Journal of Nuclear Medicine · 2016 · 278 citations · Full text

Neutralization Profiles of Primary Human Immunodeficiency Virus Type 1 Isolates in the Context of Coreceptor Usage

D. Cecilia, Vineet N. KewalRamani, Jeanne O’Leary et al. · Journal of Virology · 1998 · 215 citations · Full text

Rows per page

1–5 of 15